Unfortunately, I see that good faith has remained on only one side of this committee.
It is precisely because we believe in the work of the Auditor General that we want to get to the bottom of her report and fully understand her findings.
When she talks about wasted doses, did that happen because pharmaceutical companies took advantage of the situation to make commercial agreements with the government at the expense of taxpayer dollars?
The Auditor General could not have disclosed that kind of information in her report, as purchase options cannot be publicly disclosed. So in this case, it's simply because we want to get to the bottom of the Auditor General's report and support her work that we want access to the same contracts that she was able to see.